“Bioinformant is a wonderful and balanced source of information about cell therapies-covering all aspects of the area including existing clinical therapies, research, pipeline products and more! It’s a source I trust to keep up with this rapidly evolving field.”
Dr. Chris Centeno, M.D.
CEO of Regenexx
“Many thanks for your willingness to contribute to the progress of the stem cell field. You exude tremendous enthusiasm and it translates into your words and your work. Thank you for sharing that energy with us.”
João Andrade, CEO & Co-Founder
WideCELLS (London, England)
“I was truly impressed by BioInformant. You can trust BioInformant to do things right and generate greater awareness of your technology. They are the go-to resource for stem cell researchers and companies looking for trustworthy stem cell business information and marketing support.”
Dr. William Frey II, Founder and Co-Director
Alzheimer’s Research Center
“I am now truly enlightened. You are awesome! I must say it has been an absolute pleasure working with you folks. You will always get a great customer recommendation from me.”
Vice President, Angiocrine Bioscience
“BioInformant is a great place to get updates and share valuable information and ideas in cell therapy. With tremendous technological breakthroughs not yet translated to successes in the market, the awareness created by Bioinformant is much needed and helpful. Thank you to the knowledgeable and dedicated team that makes this happen.”
Dr. Yael Margolin
President and CEO, Gamida Cell
“Neo Matrix would like to extend a heartfelt thanks to Bioinformant and CEO Cade Hildreth in your profound dedication and passion in heading up the premier social media platform for stem cell therapy across the globe. The presentation of the most recent, continuously updated, and groundbreaking international scientific research is paving the way to help providers bridge the gap between stem cell clinical research and therapeutic applications.”
V.P. of International Communications
Neo Matrix, LLC
“BioInformant is a market research leader—there is undoubtedly no more comprehensive and unbiased cell therapy research firm in the industry. CEO Cade Hildreth is both passionate and professional about the growth and evolution of this field and, ultimately, bringing new options to patients which push forward the need of progress in medicine.”
Director of Educational Relations, Okyanos
“The BioInformant team was great to work with. The cord blood report we claimed was comprehensive and informative and the team was extremely responsive to all of our questions. I would highly recommend them to anyone interested in learning more about the cord blood and cord tissue markets.”
Private Equity Analyst, Audax Group
“We are impressed with Bioinformant, and encourage those interested in the field to follow them for up-to-date news.”
Barbara Nelsen, PhD, MBA
Founder, Nelsen Biomedical
“BioInformant is the most useful central repository of real-time information in the field of Regenerative and Translational Medicine. The resources provided for scientists, clinicians, patients, and other industry professionals interested in learning what is happening in real-time is truly invaluable. The accuracy of the information, timeliness of the information, and quality of the information make BioInformant an invaluable resource.”
Founder, Boston Biolife
“I greatly appreciate BioInformant’s efforts to educate, update and inform. I have found Cade’s writings to be a very useful way to keep up on what my colleagues and other companies are doing and reporting at meetings I am unable to attend. Keep up the good work.”
Director of Research and Development, VetStem Biopharma
“I’ve found BioInformant an invaluable resource for getting me up to speed in the cord blood and stem cells industry. They’re also a supportive organisation that genuinely wants our business to succeed! We look forward to continuing our partnership!”
Commercial Director of Phacilitate Ltd.
“It was a tremendous pleasure working with BioInformant, as they were always very accessible and cooperative. I look forward to working with BioInformant in the very near future on other projects. Cade was also very helpful in writing an article on the First Annual Inter American Stem Cell Conference to be held in Havana, Cuba on October 13-15, 2016.”
Ricardo de Cubas
President, Founder, & CEO, Regenestem
“BioInformant puts enormous time and effort into their products, which are accurate and precise. Their cord blood industry knowledge is outstanding, so cord blood banks and investors actively seek out their expertise. The BioInformant Team is very efficient and it is always a pleasure to do business with them.”
Sonja Seeburger, Business Development Manager
“BioInformant has been diligent about supporting our specific goals and investigations pertaining to growth factors and other recombinant proteins. Most importantly, our interactions with BioInformant management have been great. They’ve helped us to grow sales and better understand our clients.
Hakon Birgisson PhD, MBA, Director of Global Market Development
“BioInformant is the best site on the leaders in the field, a must read for regenerative medicine.”
Blogger at “Investor Stem Cell”
“Cade sees the real potential, direction and growing global platform for all aspects of cord blood stem cells. BioInformant believes and knows the science is hard, real and it’s happening now, not someday or in the distant future.“
Charis Ober, Co-Founder
Save the Cord Foundation
“BioInformant is professional and knowledgeable, reports accurately and operates with integrity. We’ve done three stories together. Looking forward to the next.“
Public Relations / Communications, Israeli Biotech Community
“A special effort was made to render this excellent report accessible to us. The discussions that followed were very helpful, and will contribute to the realization of our objective which is to establish a public cord blood bank in sub-Saharan Africa.”
Michael S. Pepper, MBChB, PhD, MD
Director, Institute for Cellular and Molecular Medicine
Professor, Dept. of Immunology, Faculty of Health Sciences, University of Pretoria
I would like to express my genuine feelings of gratitude for BioInformant’s exellent work. BioInformant is the most complete information source anywhere in the evolution of stem cell history.
Prof Dr Ramon Albert
President of ITERA Life-Sciences consortium
“We are so grateful to Cade Hildreth and Bioinformant for the sincere and passionate interest they have in groundbreaking stem cell research. We were impressed by their professionalism and level of dedication to delivering the latest breakthroughs in regenerative medicine to the forefront.”
Pamela Levin, RN
Public Relations/ Tisch MS Research Center of New York
“As Head of Global Outreach for Save the Cord Foundation, I am constantly working with our partners to explore creative and effective ways to promote cord blood awareness on a global level. BioInformant understands and appreciates our mission. They continue to be very pro-active in working with us and we have reached new audiences as a result. As partners in cord blood education, we share a passion for the industry and geniunely care about its future which we all agree has so much potential.”
Head of Global Outreach, Save the Cord Foundation
BioInformant is the leading site to find information about cord blood banks, to get additional answers, and to make informed choices. It was very useful for me and I will use BioInformant for further readings and questions.
BioInformant is unquestionably the leader in covering stem cell industry news, market progress, and breakthroughs. Cade has firsthand experience with the power of our own stem cells to revolutionize the practice or medicine and transform lives.
Administrator of Adult Stem Cell Advocates
Bioinformant is truly amazing in how quickly they respond and get back to you to deliver quality proven technology to the biotech industry.
President of Altucell Inc.
“Bioinformant is the serious, comprehensive and sole-focused source on stem cell research and therapy. As a result, Cade Hildreth’s market research, interviews and blogs have become my go-to source for information. She and her team provide the facts, statistics and insights that interest me. I look forward to Bioinformant leading the stem cell market forward!”
CEO and Co-Founder of Okyanos
BioInformant is the first and only market research firm to specialize in the stem cell industry. BioInformant has been cited by prominent news outlets that include the Wall Street Journal, Nature Biotechnology, Xconomy, and Vogue Magazine. Serving industry leaders that include Goldman Sachs, GE Healthcare, and Thermo Fisher Scientific, BioInformant is your global leader in stem cell industry data. View our global strategic reports for the stem cell industry.